The estimated Net Worth of Gregory Scott Meyers is at least $293 Mille dollars as of 1 February 2024. Gregory Meyers owns over 2,543 units of Bristol-Myers Squibb Co stock worth over $293,484 and over the last 3 years Gregory sold BMY stock worth over $0.
Gregory has made over 3 trades of the Bristol-Myers Squibb Co stock since 2023, according to the Form 4 filled with the SEC. Most recently Gregory exercised 2,543 units of BMY stock worth $123,564 on 1 February 2024.
The largest trade Gregory's ever made was exercising 2,836 units of Bristol-Myers Squibb Co stock on 10 March 2023 worth over $137,801. On average, Gregory trades about 1,320 units every 61 days since 2022. As of 1 February 2024 Gregory still owns at least 6,040 units of Bristol-Myers Squibb Co stock.
You can see the complete history of Gregory Meyers stock trades at the bottom of the page.
Gregory's mailing address filed with the SEC is BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543.
Over the last 17 years, insiders at Bristol-Myers Squibb Co have traded over $318,151,721 worth of Bristol-Myers Squibb Co stock and bought 211,503 units worth $6,601,565 . The most active insiders traders include Lamberto Andreotti, James M Cornelius e Giovanni Caforio. On average, Bristol-Myers Squibb Co executives and independent directors trade stock every 8 days with the average trade being worth of $1,682,720. The most recent stock trade was executed by Cari Gallman on 1 August 2024, trading 1,061 units of BMY stock currently worth $51,554.
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol-Myers Squibb Co executives and other stock owners filed with the SEC include: